We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+17.63%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$808M
AUM Growth
+$311M
Cap. Flow
+$255M
Cap. Flow %
31.62%
Top 10 Hldgs %
37.23%
Holding
104
New
33
Increased
25
Reduced
12
Closed
31

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$46.9M
2
ZBH icon
Zimmer Biomet
ZBH
+$40.8M
3
MCK icon
McKesson
MCK
+$27.7M
4
THC icon
Tenet Healthcare
THC
+$16.5M
5
BSX icon
Boston Scientific
BSX
+$16.4M

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$14.3M
2
TFX icon
Teleflex
TFX
+$11.7M
3
CAH icon
Cardinal Health
CAH
+$11.5M
4
BIIB icon
Biogen
BIIB
+$11.1M
5
IDXX icon
Idexx Laboratories
IDXX
+$10M

Sector Composition

Rank Sector Weight
1 Healthcare 94.35%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
1
Cigna
CI
$73.7B
$50.5M 6.25%
+180,000
New +$46.9M
ZBH icon
2
Zimmer Biomet
ZBH
$18.2B
$43.7M 5.41%
+300,000
New +$40.8M
NVO
3
PUT
Novo Nordisk
NVO
$208B
$40.5M 5.01%
+500,000
New +$40.8M
INSP icon
4
Inspire Medical Systems
INSP
$1.45B
$33.4M 4.14%
103,000
+23,000
+29% +$6.57M
MCK icon
5
McKesson
MCK
$100B
$30.8M 3.81%
+72,000
New +$27.7M
BSX icon
6
Boston Scientific
BSX
$69.5B
$25.2M 3.12%
466,000
+314,000
+207% +$16.4M
CYTK icon
7
Cytokinetics
CYTK
$10.5B
$21.2M 2.63%
650,000
+50,000
+8% +$1.85M
COO icon
8
Cooper Companies
COO
$14.1B
$19.9M 2.47%
208,000
+48,000
+30% +$4.5M
THC icon
9
Tenet Healthcare
THC
$20.5B
$18.9M 2.34%
+232,000
New +$16.5M
RVTY icon
10
Revvity
RVTY
$12.6B
$16.6M 2.06%
140,000
+55,000
+65% +$6.76M
ARGX icon
11
argenx
ARGX
$53.4B
$15.6M 1.93%
40,000
+28,000
+233% +$11M
MLTX icon
12
MoonLake Immunotherapeutics
MLTX
$1.57B
$15.3M 1.89%
+300,000
New +$8.07M
EHC icon
13
Encompass Health
EHC
$11B
$14.9M 1.84%
+220,000
New +$13.8M
GH icon
14
Guardant Health
GH
$21.7B
$14.7M 1.83%
412,000
+62,000
+18% +$1.78M
HOLX
15
DELISTED
Hologic
HOLX
$14.2M 1.75%
175,000
+100,000
+133% +$8.17M
LLY icon
16
Eli Lilly
LLY
$1.02T
$14.1M 1.74%
+30,000
New +$12.6M
CNC icon
17
Centene
CNC
$30.7B
$13.5M 1.67%
+200,000
New +$13.3M
ABBV icon
18
AbbVie
ABBV
$443B
$13.5M 1.67%
100,000
+19,000
+23% +$2.79M
ELV icon
19
Elevance Health
ELV
$81.5B
$13.3M 1.65%
30,000
-21,000
-41% -$9.69M
SDGR icon
20
Schrodinger
SDGR
$1.13B
$13.2M 1.64%
+265,000
New +$8.95M
ZNTL icon
21
Zentalis Pharmaceuticals
ZNTL
$337M
$12.7M 1.57%
450,000
-150,000
-25% -$3.6M
GSK icon
22
GSK
GSK
$104B
$12.5M 1.54%
+350,000
New +$12.6M
ISRG icon
23
Intuitive Surgical
ISRG
$127B
$12.3M 1.52%
+36,000
New +$10.9M
RETA
24
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$12.2M 1.52%
120,000
+49,000
+69% +$4.64M
HCA icon
25
HCA Healthcare
HCA
$87.2B
$12.1M 1.5%
40,000
-5,000
-11% -$1.39M
1
2 3 4 5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Integral Health Asset Management held 104 positions worth $808M, up 63% from $496M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Integral Health Asset Management deployed $255M of net new capital in Q2 2023, opening 33 new positions and adding to 25 existing holdings. Its largest new stake was Cigna: 180,000 shares worth $50.5M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 97% a quarter earlier, followed by Consumer Staples.

On the sell side, the largest reduction was Elevance Health, an estimated $9.69M trimmed.

  • Integral Health Asset Management's largest Q2 2023 buy was Cigna: 180,000 shares worth $50.5M.
  • Integral Health Asset Management added most to Boston Scientific in Q2 2023, an estimated $16.4M increase.
  • Integral Health Asset Management's biggest Q2 2023 reduction was Elevance Health, cutting an estimated $9.69M.
  • Integral Health Asset Management fully exited Stryker in Q2 2023, selling an estimated $14.3M.
  • Integral Health Asset Management's ten largest holdings make up 37% of its $808M portfolio in Q2 2023.
  • Integral Health Asset Management opened 33 new positions and closed 31 in Q2 2023.
  • Integral Health Asset Management's portfolio value rose 63% quarter-over-quarter to $808M.

Based on Integral Health Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.